Table S2. Survival status, microbiology results and nosocomial infection site in patients who developed nosocomial infection. (DOCX 12Â kb
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
Figure S6. Comparison by nosocomial infection status. Comparison of expression of PD-1, PD-L1 and PD...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Figure S9. Comparison by survival status. Comparison of PD-1, PD-L1 and PD-L2 expression by B and CD...
Figure S10. Serum level comparison. Comparison of levels of serum PD-1 and PD-L1 between patients wi...
Table S6. sPD-1/sPD-L1 studies in sepsis. Summary of previous studies measuring soluble serum PD-1 a...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Figure S11. Serum versus cell surface expression. Serum levels of PD-1 and PD-L1 are plotted against...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Figure S8. Comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. Co...
Figure S4. CD4+ T cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined b...
Figure S2. B cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined by MFI...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
Figure S6. Comparison by nosocomial infection status. Comparison of expression of PD-1, PD-L1 and PD...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Figure S9. Comparison by survival status. Comparison of PD-1, PD-L1 and PD-L2 expression by B and CD...
Figure S10. Serum level comparison. Comparison of levels of serum PD-1 and PD-L1 between patients wi...
Table S6. sPD-1/sPD-L1 studies in sepsis. Summary of previous studies measuring soluble serum PD-1 a...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Figure S11. Serum versus cell surface expression. Serum levels of PD-1 and PD-L1 are plotted against...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Figure S8. Comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. Co...
Figure S4. CD4+ T cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined b...
Figure S2. B cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined by MFI...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
DOI
Add to ORKG